Statistics for Prolonged Response to Anti–PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden
Total visits
| views | |
|---|---|
| Prolonged Response to Anti–PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden | 197 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Gbolahan_2019_prolonged.pdf | 254 |
| java.util.UUID:1c9de437-959a-440b-b54f-7753cac0119b | 28 |
| java.util.UUID:48600065-1362-453b-b0de-6067f6269b52 | 10 |
| java.util.UUID:d82099a3-f548-45c1-9934-d9be64659a10 | 7 |
Top country views
| views | |
|---|---|
| United States | 170 |
| China | 4 |
| Germany | 3 |
| Canada | 2 |
| Belgium | 1 |
| Ireland | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 57 |
| Fairfield | 25 |
| Houston | 18 |
| Cambridge | 17 |
| Jacksonville | 5 |
| Beijing | 4 |
| Ann Arbor | 3 |
| San Francisco | 3 |
| Kiez | 2 |
| Toronto | 2 |
| Augusta | 1 |
| Baltimore | 1 |
| Dublin | 1 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Islamabad | 1 |
| Kiev | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Zaventem | 1 |